Programming peptidomimetic syntheses by translating genetic codes designed de novo
AUTOR(ES)
Forster, Anthony C.
FONTE
National Academy of Sciences
RESUMO
Although the universal genetic code exhibits only minor variations in nature, Francis Crick proposed in 1955 that “the adaptor hypothesis allows one to construct, in theory, codes of bewildering variety.” The existing code has been expanded to enable incorporation of a variety of unnatural amino acids at one or two nonadjacent sites within a protein by using nonsense or frameshift suppressor aminoacyl-tRNAs (aa-tRNAs) as adaptors. However, the suppressor strategy is inherently limited by compatibility with only a small subset of codons, by the ways such codons can be combined, and by variation in the efficiency of incorporation. Here, by preventing competing reactions with aa-tRNA synthetases, aa-tRNAs, and release factors during translation and by using nonsuppressor aa-tRNA substrates, we realize a potentially generalizable approach for template-encoded polymer synthesis that unmasks the substantially broader versatility of the core translation apparatus as a catalyst. We show that several adjacent, arbitrarily chosen sense codons can be completely reassigned to various unnatural amino acids according to de novo genetic codes by translating mRNAs into specific peptide analog polymers (peptidomimetics). Unnatural aa-tRNA substrates do not uniformly function as well as natural substrates, revealing important recognition elements for the translation apparatus. Genetic programming of peptidomimetic synthesis should facilitate mechanistic studies of translation and may ultimately enable the directed evolution of small molecules with desirable catalytic or pharmacological properties.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164450Documentos Relacionados
- De novo designed cyclic-peptide heme complexes
- De novo designed peptide-based amyloid fibrils
- De novo amyloid proteins from designed combinatorial libraries
- On the failure of de novo-designed peptides as biocatalysts.
- Conformational dependence of electron transfer across de novo designed metalloproteins.